NEW YORK, May 22, 2017 /PRNewswire/ --
Highlights
- The interventional cardiology and peripheral vascular devices
market is expected to reach USD 31.47
billion by 2021 from USD 21.83
billion in 2016, at a CAGR of 7.1%.
- In 2016, the IVUS/OCT segment is projected to witness the
highest growth in this market due to increasing penetration rates
and rapid advancements & innovations in these systems.
- Growth in the North American region is primarily driven by the
rising incidence of cardiovascular diseases, rapidly growing
geriatric population, and technological advancements.
- On the basis of type, the EVAR stent grafts market is segmented
into abdominal aortic aneurysms and thoracic aortic aneurysms.
- In 2016, the abdominal aortic aneurysms segment is projected to
witness the highest growth in this market due to the rising
incidence of smoking and hypertension.
- This report will enable both established firms as well as new
entrants/smaller firms to gauge the pulse of the market, which in
turn will help these firms garner greater market shares.
- Competitive Assessment: In-depth assessment of the market
strategies, geographic and business segments, and product
portfolios of the leading players in the interventional cardiology
and peripheral vascular devices market.
The interventional cardiology and peripheral vascular devices
market is expected to reach USD 31.47
billion by 2021 from USD 21.83
billion in 2016, at a CAGR of 7.1%. On the basis of product,
this market is broadly classified into angioplasty balloons,
angioplasty stents, catheters, EVAR stent grafts, IVC filters,
plaque modification devices, hemodynamic flow alteration devices,
and accessories.
On the basis of type, the angioplasty stents market is segmented
into drug-eluting stents, bare-metal stents, and bioabsorbable
stents. The drug-eluting stents segment is projected to witness the
highest growth in this market due to increasing number of
regulatory approvals and new product launches.
On the basis of type, the catheters market is segmented into
IVUS/OCT, angiography catheters, and guiding catheters. In 2016,
the IVUS/OCT segment is projected to witness the highest growth in
this market due to increasing penetration rates and rapid
advancements & innovations in these systems.
On the basis of type, the EVAR stent grafts market is segmented
into abdominal aortic aneurysms and thoracic aortic aneurysms. In
2016, the abdominal aortic aneurysms segment is projected to
witness the highest growth in this market due to the rising
incidence of smoking and hypertension.
Geographically, the interventional cardiology and peripheral
vascular devices market is dominated by North America, followed by Europe, Asia,
and the Rest of the World (RoW). Growth in the North American
region is primarily driven by the rising incidence of
cardiovascular diseases, rapidly growing geriatric population, and
technological advancements.
Research Coverage:
In addition to comprehensive geographic and product analysis and
market sizing, the report also provides a competitive landscape
that covers the growth strategies adopted by industry players over
the last three years. The company profiles in this report comprise
the product portfolios, developments, and strategies adopted by
players to maintain and increase their shares in the market. The
abovementioned market research data, current market size, and
forecast of future trends will help key market players and new
entrants to make the necessary decisions regarding product
offerings, geographic focus, change in strategic approach, and
levels of output in order to remain successful in the
interventional cardiology and peripheral vascular devices
market.
The key players in the interventional cardiology and peripheral
vascular devices market include Abbott Laboratories (U.S.), Boston
Scientific Corporation (U.S.), B. Braun Melsungen AG (Germany), Cordis Corporation (U.S.), C.R.
Bard, Inc. (U.S.), Medtronic plc (U.S.), and Terumo Corporation
(Japan).
Reasons to Buy the Report:
This report will enable both established firms as well as new
entrants/smaller firms to gauge the pulse of the market, which in
turn will help these firms garner greater market shares. Firms
purchasing the report can use any one or a combination of the
below-mentioned five strategies (market penetration, product
development/innovation, market development, market diversification,
and competitive assessment) for strengthening their market
shares.
The report provides insights on the following
pointers:
- Market Penetration: Comprehensive information on the product
portfolios of the top players in the interventional cardiology and
peripheral vascular devices market. The report analyses the
interventional cardiology and peripheral vascular devices market by
angioplasty balloons, angioplasty stents, catheters, EVAR stent
grafts, IVC filters, plaque modification devices, hemodynamic flow
alteration devices, and accessories
- Product Development/Innovation: Detailed insights on the upcoming
technologies, R&D activities, and new product launches in the
interventional cardiology and peripheral vascular devices
market
- Competitive Assessment: In-depth assessment of the market
strategies, geographic and business segments, and product
portfolios of the leading players in the interventional cardiology
and peripheral vascular devices market
- Market Development: Comprehensive information about emerging
markets. This report analyzes the market for various interventional
cardiology and peripheral vascular devices across geographies
- Market Diversification: Exhaustive information about new
products, untapped geographies, recent developments, and
investments in the interventional cardiology and peripheral
vascular devices market
Read the full report:
http://www.reportlinker.com/p04534881/Interventional-Cardiology-Peripheral-Vascular-Devices-Market-by-Type-Forecasts-to.html
About Reportlinker
ReportLinker is an award-winning market research solution.
Reportlinker finds and organizes the latest industry data so you
get all the market research you need - instantly, in one place.
http://www.reportlinker.com
__________________________
Contact Clare: clare@reportlinker.com
US: (339)-368-6001
Intl: +1 339-368-6001
To view the original version on PR Newswire,
visit:http://www.prnewswire.com/news-releases/interventional-cardiology--peripheral-vascular-devices-market-is-expected-to-reach-usd-3147-billion-by-2021-300461877.html
SOURCE Reportlinker